AMICUS THERAPEUTICS INC. - COMMON STOCK
9,6300
27-декабря-24 15:45:00
15 мин. задержка
Акции
-0,1400
-1,43%
Сегодняшний диапазон
9,5500 - 9,7900
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
01 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
28 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
15 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
08 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
01 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
07 янв 2024 15:00:52 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
05 дек 2023 05:00:38 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
08 ноя 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
01 ноя 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
27 окт 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
03 окт 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
02 окт 2023 07:20:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
28 сен 2023 09:41:45 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
01 сен 2023 06:00:18 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023
29 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
21 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
15 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
08 авг 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Second Quarter 2023 Financial Results on August 8, 2023
31 июл 2023 06:00:00 Источник Nasdaq GlobeNewswire